139 related articles for article (PubMed ID: 2478749)
1. Localization of decay accelerating factor in normal and diseased kidneys.
Cosio FG; Sedmak DD; Mahan JD; Nahman NS
Kidney Int; 1989 Jul; 36(1):100-7. PubMed ID: 2478749
[TBL] [Abstract][Full Text] [Related]
2. Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney.
Abe K; Miyazaki M; Koji T; Furusu A; Ozono Y; Harada T; Sakai H; Nakane PK; Kohno S
Kidney Int; 1998 Jul; 54(1):120-30. PubMed ID: 9648070
[TBL] [Abstract][Full Text] [Related]
3. Localization of the complement regulatory proteins in the normal human kidney.
Ichida S; Yuzawa Y; Okada H; Yoshioka K; Matsuo S
Kidney Int; 1994 Jul; 46(1):89-96. PubMed ID: 7523758
[TBL] [Abstract][Full Text] [Related]
4. Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis.
Sogabe H; Nangaku M; Ishibashi Y; Wada T; Fujita T; Sun X; Miwa T; Madaio MP; Song WC
J Immunol; 2001 Sep; 167(5):2791-7. PubMed ID: 11509624
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of autologous antibodies and decay-accelerating factor, an inhibitor of complement, on human renal tumor cells.
Terachi T; Stanescu G; Pontes JE; Medof ME; Caulfield MJ
Cancer Res; 1991 May; 51(10):2521-3. PubMed ID: 1708695
[TBL] [Abstract][Full Text] [Related]
6. Decay-accelerating factor in the cardiomyocytes of normal individuals and patients with myocardial infarction.
Zimmermann A; Gerber H; Nussenzweig V; Isliker H
Virchows Arch A Pathol Anat Histopathol; 1990; 417(4):299-304. PubMed ID: 1700536
[TBL] [Abstract][Full Text] [Related]
7. Heme Oxygenase 1 Up-Regulates Glomerular Decay Accelerating Factor Expression and Minimizes Complement Deposition and Injury.
Detsika MG; Duann P; Atsaves V; Papalois A; Lianos EA
Am J Pathol; 2016 Nov; 186(11):2833-2845. PubMed ID: 27662796
[TBL] [Abstract][Full Text] [Related]
8. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
[TBL] [Abstract][Full Text] [Related]
9. Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytes.
Bao L; Spiller OB; St John PL; Haas M; Hack BK; Ren G; Cunningham PN; Doshi M; Abrahamson DR; Morgan BP; Quigg RJ
Kidney Int; 2002 Dec; 62(6):2010-21. PubMed ID: 12427125
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of decay-accelerating factor and HLA-DR within the CD8-brightly positive population.
Tomita A; Okada N; Okada H
Eur J Immunol; 1991 Aug; 21(8):1843-8. PubMed ID: 1714392
[TBL] [Abstract][Full Text] [Related]
11. Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells.
Cosio FG; Shibata T; Rovin BH; Birmingham DJ
Kidney Int; 1994 Oct; 46(4):986-92. PubMed ID: 7532249
[TBL] [Abstract][Full Text] [Related]
12. Complement activation induces the expression of decay-accelerating factor on human mesangial cells.
Shibata T; Cosio FG; Birmingham DJ
J Immunol; 1991 Dec; 147(11):3901-8. PubMed ID: 1719094
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of membrane cofactor protein (CD46) in the human kidneys.
Nakanishi I; Moutabarrik A; Hara T; Hatanaka M; Hayashi T; Syouji T; Okada N; Kitamura E; Tsubakihara Y; Matsumoto M
Eur J Immunol; 1994 Jul; 24(7):1529-35. PubMed ID: 8026516
[TBL] [Abstract][Full Text] [Related]
14. Decay accelerating factor regulates complement activation on glomerular epithelial cells.
Quigg RJ; Nicholson-Weller A; Cybulsky AV; Badalamenti J; Salant DJ
J Immunol; 1989 Feb; 142(3):877-82. PubMed ID: 2464030
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys.
Yoshioka K; Takemura T; Murakami K; Okada M; Hino S; Miyamoto H; Maki S
Lab Invest; 1993 Feb; 68(2):154-63. PubMed ID: 8441250
[TBL] [Abstract][Full Text] [Related]
16. Generation of a novel decay accelerating factor (DAF) knock-out rat model using clustered regularly-interspaced short palindromic repeats, (CRISPR)/associated protein 9 (Cas9), genome editing.
Detsika MG; Goudevenou K; Geurts AM; Gakiopoulou H; Grapsa E; Lianos EA
Transgenic Res; 2021 Feb; 30(1):11-21. PubMed ID: 33387103
[TBL] [Abstract][Full Text] [Related]
17. Role of human decay-accelerating factor in the evasion of Schistosoma mansoni from the complement-mediated killing in vitro.
Horta MF; Ramalho-Pinto FJ
J Exp Med; 1991 Dec; 174(6):1399-406. PubMed ID: 1720809
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis.
Simpson KL; Holmes CH
Immunology; 1994 Mar; 81(3):452-61. PubMed ID: 7515850
[TBL] [Abstract][Full Text] [Related]
19. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
Lublin DM; Coyne KE
J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
[TBL] [Abstract][Full Text] [Related]
20. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
